Skip to main content

Peer Review reports

From: Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions

Original Submission
15 Sep 2024 Submitted Original manuscript
6 Oct 2024 Reviewed Reviewer Report
21 Oct 2024 Reviewed Reviewer Report
8 Dec 2024 Reviewed Reviewer Report
6 Jan 2025 Author responded Author comments - Yang Song
13 Jan 2025 Reviewed Reviewer Report
31 Mar 2025 Author responded Author comments - Yang Song
Resubmission - Version 2
6 Jan 2025 Submitted Manuscript version 2
11 Apr 2025 Author responded Author comments - Yang Song
Resubmission - Version 3
11 Apr 2025 Submitted Manuscript version 3
Publishing
11 Apr 2025 Editorially accepted
29 Apr 2025 Article published 10.1186/s12916-025-04075-1

You can find further information about peer review here.

Back to article page